Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. (BARI-COVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04320277
Recruitment Status : Unknown
Verified April 2020 by Fabrizio Cantini, Hospital of Prato.
Recruitment status was:  Not yet recruiting
First Posted : March 24, 2020
Last Update Posted : April 22, 2020
Information provided by (Responsible Party):
Fabrizio Cantini, Hospital of Prato

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : July 30, 2020

Publications automatically indexed to this study by Identifier (NCT Number):